*

JUAN G. FLOREZ – HANSSEN

***** *** **** **., **********, FL 33324

adt80q@r.postjobfree.com 786-***-****

Senior Executive Healthcare, Consumer Goods, Tech, Retail Multinationals & Private Equity Strategy Finance Operations Transformation executive with a solid leadership career at corporations and private equity firms, across various industries. Experienced in deep strategic analysis and proficient at setting companies up for Long Term Success. Capable of translating the business reason for being, by identifying core growth drivers, as determined by market and competition. Helped build multiple strategic plans, managed consistent KPI tracking systems, and facilitated a result oriented and goal achievement culture. Executed effective capital allocation, as well as designed effective compensation plans. Involved in multiple value creation M&A transactions, including closure of deals. Identified, attracted, developed, and promoted multiple high potential individuals. Worked in seven countries, across North America, Europe, and Latin America.

EDUCATION

COLUMBIA BUSINESS SCHOOL, NY – Executive Education

• Chief Financial Officer Program, 2022-2023

• Value Investing, 2022

INALDE BUSINESS SCHOOL - Colombia - Director’s Development Program WHARTON BUSINESS SCHOOL – Philadelphia, PA – CFO: Becoming a Strategic Partner UNIVERSIDAD DE LOS ANDES - Colombia - Bachelor’s in Business Administration / Postgraduate – Finance EXPERIENCE

StarLIMS, a Francisco Partners company (formerly Abbott Informatics Unit in ABBOTT LABORATORIES) Senior Director, Finance, Hollywood, Florida 2021 – 2022 Reporting to the new CFO, lead the transition from a Corporation Business Unit to a full-blown stand-alone business, upon the acquisition of Abbott’s StarLIMS (formerly Abbott Informatics) by Francisco Partners, a Private Equity firm.

• With a fast-track agenda of 6 months defined by the Purchase agreement, set a dynamic “carve-out” Plan, across all functions.

• Deployed within two months Private Equity reporting systems (Customer Churn, SaaS reports, Banks Debt Reporting).

• Engaged and implemented Oracle’s Netsuite to exit from Abbott’s financial systems. Lead team that migrated all financial processes (A/P, A/R, Payroll), as well as enhanced FP&A and Analytics.

• Set up new finance functions (Treasury, Taxes, Procurement, Insurance) formerly run by Abbott. Maintained stability by means of a well thought retention plan and leadership presence. Achieved first three quarters results as per Business Plan. ABBOTT LABORATORIES, Healthcare leading company in generics, diagnostics, nutrition & medical devices. Finance Head / Global Controller, Abbott Informatics - Hollywood, Florida 2016 - 2021 Together with the Division President, turned around the Abbott Informatics Business Unit (part of Diagnostics Division), which facilitated the subsequent divestiture of the business. This business focuses on Laboratory Information software solutions across Life Sciences, Quality Manufacturing, Environmental and Forensics.

• With lagging sales and a challenging P&L, took decisive action to invest in fixing the software products, build a new commercial organization and focus on reliable project implementation delivery.

• Transformed Finance by overhauling forecasting & demand process accuracy, as well as improving operational accountability.

• Inspired the organization to advance the speed and quality of customer delivery and kept morale high cognizant that winds of change were approaching.

• After three years, sales returned to mid-single digit growth and gross margins improved by 7 pp, which resulted in operation margins reaching 12 %. The unit became attractive for an acquirer and became divested after a competitive bidding. 2

Director, Abbott Corporate Finance, Lake County, Illinois 2014 – 2016 Held simultaneously the role of Finance Integration Leader of two key acquisitions for Abbott: CFR Recalcine in Latin America ($3.3 Bn.)

& Veropharm in Russia ($305 Million).

• With the mission of expanding with acquisitions Abbott’s Branded Generics franchise across emerging markets, was involved as team leader of twenty that executed all steps required to close the mentioned transactions, such as due diligence, deal models, business valuations, financial close considerations, purchase accounting, finance integration plans, as well as monitor the proper execution of treasury and tax considerations.

• Lead intensive interaction, coordination, and cross-consulting across the other seven different functional acquisition teams.

• On-boarded acquired companies upon Day 1 into Abbott Shared Services, providing for timely reporting.

• In 2015, became appointed by headquarters to assist Abbott Brazil’s Management Team to lead a nine-month cross functional business stabilization effort, derived from an acute operational crisis caused by a flawed ERP system implementation project, which severely hurt sales, profitability, and business reputation. Earned for this achievement the Abbott President’s Award. Finance Director, Abbott Russia, Moscow 2010 - 2014 Given the mission of rapidly onboarding acquired Europe’s Solvay Pharmaceutical business, hired to return to Abbott as one of two expatriates in Russia, the largest Abbott’s European business. Longer term strategy included splitting Abbott into two (Abbott and AbbVie) and called for pursuing inorganic expansion options in the Branded Generics space at Emerging Markets.

• Executed flawlessly Integration with Solvay while simultaneously separating Biopharmaceutical business to AbbVie.

• Retained full responsibility for Abbott Finance back-office operations, while providing Service agreement to AbbVie.

• After effective product cross-promotion given the Sales Force synergies and successful launches, developed the top line beyond the $500 M level, with outstanding years of 20 % + growth.

• Strengthened internal controls via ERP deployment and elevated the level of FP&A, Controlling, IT and Financial Services. Created the Pricing Team, to navigate carefully through the complex Russian pricing regulations that favored locals.

• After three years, a record 76% gross margin allowed the subsidiary to reach select club of 50 % + Operating Margin, a benchmark in the Abbott world. Pursued Russian acquisitions, one failed; finally succeeded acquiring Veropharm, a leading Russian generics company. Received two Corporate Officers recognitions:

• Abbott’s CEO Recognition for leading role in worldwide separation of Abbott / AbbVie.

• Abbott Emerging Markets President Recognition for execution of HIV therapy tender in Russia. PFIZER, Pharmaceutical and vaccines world’s leading company. Finance Director, Pfizer Argentina, Buenos Aires 2010 With the Pneumococcus Vaccine key critical challenge of accomplishing full population immunization status, In Argentina Pfizer required integration with Wyeth within 6 months, which called for an aggressive Legal and Finance plan to integration.

• Coming from Wyeth Brazil, as the sole Wyeth-side executive at Pfizer Argentina.

• Successfully ran the Integration of Pfizer & Wyeth in Argentina via an innovative reverse integration strategy.

• Was able to ensure that given the regulatory hurdles, Wyeth would not face delays in Pneumococcus Vaccine registration and universal immunization status.

WYETH, Pharmaceuticals, Nutrition and Vaccines Global Company, acquired by Pfizer in 2009. Chief Financial Officer & Business Development Director, Wyeth Brazil, São Paulo 2008 - 2010 The business in Brazil, a large Commercial and Manufacturing Affiliate, had faced years of operational challenges, which impacted growth and market share. In 2008, headquarters decided to make a complete change in management team. The challenge was to perform a turnaround of the Affiliate with the goal of bringing it back to become a top ten pharma company in Brazil.

• Optimizing investments, focused on investing in the chronic auto-immune disease therapies for Arthritis and Psoriasis, which resulted in record Sales of $300 M in 09, The strategy allowed for a 14 % CAGR % top line growth 07 – 10.

• Directly supervised Wyeth Brazil business development team, performing innumerous projects, amongst others:

• Out-licensing of Wyeth s Oral Contraceptive / Women s Health business,

• Exploration for local manufacturing of Nutrition s Baby Formulas and other food supplements.

• Out-licensing and divestiture of non-core hospital business 3

Finance Director, Wyeth North Andes Region (Colombia, Ecuador & Peru), Bogotá 2004 – 2008 With the business moving from traditional established products to new biological chronic therapies, the problem that required fixing was the modernization of Wyeth’s Colombia finance organization, as well as the creation of a region, to align Finance with the Business.

• Focused on improving productivity and thereafter allocating resources for commercial capabilities, for example:

• The fast development of core specialty products.

• Having the proper cost / pricing analytics to include Pneumococcal Vaccine in Peruvian’s national immunization program.

• Launching media campaign for the first time ($450 K) in Nutrition brands to penetrate the growing toddler’s category.

• Generated savings of $1.0 M annually by implementing a Shared Service Center for all financial processes in the Andes Region.

• Elevated business discussion by deploying Kaplan’s Balanced Scorecard KPI’s Methodology, aimed at measuring strategy effectively by having the right leading KPI’s at the operational level to drive the lagging indicators.

• The synergies created at the Andes Region countries resulted in sales achieving $150 M in 2007, with CAGR% of 17 % between

04 - 07 and EBIT profile of 38 %.

CARULLAVIVERO (GROUPE CASINO), Global Retailer, #1 mass retailer in Brazil & Colombia. Chief Financial Officer, CarullaVivero, Bogotá 2004 The Azout family had merged Carulla with Vivero and obtained funding from Private Equity’s Newbridge. The new organization (Sales of $ 1.0 Bn, #2 in the market) was in the process of successfully integrating and release for sale to a top global retailer.

• Executed Bonds emission to finance stores expansion and improve EBITDA.

• Restructured Debt Profile to improve credit ratings, reduce financing cost and better position the company for buyers.

• Implemented suppliers Payment Cycle Metric based in store inventory levels to improved Cash Flows (CCC) by 12 days.

• Prepared the company financial controls and reporting for potential acquirers, namely Wal-Mart, Carrefour, & the final acquirer, Groupe Casino.

PEPSICO (FRITO LAY), Diversified foods, snacks, and beverage multinational corporation. Finance Director, Frito-Lay Colombia, Bogotá 1999 - 2004 By 1999, Colombia was the only market globally where Frito-Lay had not advanced their market dominance, by acquiring the top salty snack players and obtain market share > 50 % with the “irresistibility” concept. Part of a team hired to execute that vision.

• Drove the startup of Frito-Lay operation in Colombia, by acquiring three of the largest salty snacks local producers.

• Invested in commercial and manufacturing to advance in PepsiCo’s universal distribution “down the street” system.

• Brought acquired businesses to standards deploying controls and ERP systems.

• From scratch achieved Sales of $100 M in 3 years through heavy brand and promotional investment and product innovation.

• Elevated gross margin up by 12 p.p. by actively managing potato/corn meal suppliers.

• To increase share-of-stomach, envisioned, and developed business plan for the construction of biscuits factory (GAMESA) and subsequent business launch.

OTHER EXPERIENCE

• Finance Director, Abbott Colombia: First management position held.

• Treasurer LATAM Abbott (Chicago HQ): Cash Management, F/X Hedging, Banking Negotiations. Dividends.

• FP&A Manager, Abbott Colombia: Budgets, 3/5 Year Plans, Forecasts, Quarter confirmations, Financial Analysis, Standard Costs, Manufacturing Finance.

• Audit & Public Accounting, Deloitte Colombia: statutory accounting & audit work, mostly in Manufacturing, Oil/Gas and Banking.

ADDITIONAL INFORMATION

• Native tongue is Spanish, also fully proficient in English and Portuguese, basic knowledge of Russian.

• Involved with the South Florida Real Estate Community, volunteer as Board Member at the Harbour House Condominium Association in Bal Harbour, FL. • 450 condominiums, $6.0 M annual budget.

• Legally authorized to work in the U.S. (Green-Card).

Contact this candidate